Trials / Conditions / Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
6 registered clinical trials studyying Moderately to Severely Active Ulcerative Colitis — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moder NCT07158242 | Hoffmann-La Roche | Phase 3 |
| Recruiting | A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis NCT07035041 | InventisBio Co., Ltd | Phase 2 |
| Recruiting | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Pa NCT06588855 | Hoffmann-La Roche | Phase 3 |
| Active Not Recruiting | A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenanc NCT06589986 | Hoffmann-La Roche | Phase 3 |
| Unknown | A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis NCT04176588 | Everstar Therapeutics Limited | Phase 3 |
| Recruiting | Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis NCT03221036 | Takeda | Phase 3 |